This is a Validated Antibody Database (VAD) review about cow CDH1, based on 204 published articles (read how Labome selects the articles), using CDH1 antibody in all methods. It is aimed to help Labome visitors find the most suited CDH1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDH1 synonym: cadherin-1; E-cadherin; cadherin 1, type 1, E-cadherin (epithelial); epithelial cadherin

Abcam
rabbit polyclonal
  • western blot; human; fig 5
Abcam CDH1 antibody (Abcam, ab16505) was used in western blot on human samples (fig 5). Cell Res (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:250; fig 1
Abcam CDH1 antibody (Abcam, 16505) was used in western blot on human samples at 1:250 (fig 1). Virology (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s3
In order to utilize a novel mouse model with retinal detachment caused by a disruption of protein kinase C, theta, to study retinal pigment epithelium atrophy 1 (rpea1), Abcam CDH1 antibody (Abcam, ab6529-200) was used in immunohistochemistry - paraffin section on mouse samples (fig s3). Invest Ophthalmol Vis Sci (2016) ncbi
rabbit polyclonal
  • western blot; zebrafish ; 1:50,000; fig 2
Abcam CDH1 antibody (abcam, ab16505) was used in western blot on zebrafish samples at 1:50,000 (fig 2). PLoS ONE (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig s3b
In order to identify the enzymes and mechanisms responsible for human telomerase RNA degradation, Abcam CDH1 antibody (Abcam, ab16505) was used in immunocytochemistry on human samples (fig s3b). Nat Struct Mol Biol (2016) ncbi
rabbit polyclonal
  • western blot; zebrafish ; 1:50,000; fig 5
Abcam CDH1 antibody (Abcam, ab16505) was used in western blot on zebrafish samples at 1:50,000 (fig 5). PLoS ONE (2016) ncbi
rabbit polyclonal
  • western blot; zebrafish ; 1:50,000; fig 5
Abcam CDH1 antibody (Abcam, ab16505) was used in western blot on zebrafish samples at 1:50,000 (fig 5). Int J Mol Sci (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human
  • western blot; mouse
Abcam CDH1 antibody (Abcam, ab6529) was used in immunocytochemistry on human samples and in western blot on mouse samples . J Neurosci (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:500
Abcam CDH1 antibody (Abcam, ab-6529) was used in immunocytochemistry on human samples at 1:500. J Cell Physiol (2014) ncbi
rabbit polyclonal
  • western blot; human
Abcam CDH1 antibody (Abcam, Ab16505) was used in western blot on human samples . J Hepatol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human
Abcam CDH1 antibody (Abcam, ab16505) was used in immunocytochemistry on human samples . Cell Cycle (2013) ncbi
Proteintech Group
rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 3b
  • western blot; human; loading ...; fig 2c
Proteintech Group CDH1 antibody (Proteintech, 20874-1-AP) was used in immunocytochemistry on human samples (fig 3b) and in western blot on human samples (fig 2c). Front Physiol (2018) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Proteintech Group CDH1 antibody (Proteintech Group, 20874-1-AP) was used in western blot on human samples (fig 1d). Cancer Lett (2018) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig s2
Proteintech Group CDH1 antibody (Proteintech, 20874-1-AP) was used in western blot on human samples (fig s2). Oncotarget (2017) ncbi
rabbit polyclonal
  • western blot; mouse; fig 5
In order to investigate the role of TGF-beta signaling in bladder cancer progression, Proteintech Group CDH1 antibody (ProteinTech, 20874-1-AP) was used in western blot on mouse samples (fig 5). Sci Rep (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:200; fig 5
In order to study the role of autophagy factors in cancer progression and treatment response, Proteintech Group CDH1 antibody (Proteintech, 20874-1-AP) was used in immunohistochemistry on human samples at 1:200 (fig 5). Nat Commun (2015) ncbi
Cell Signaling Technology
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4i
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4i). Biosci Rep (2019) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 52 ng/ml; loading ...; fig 5d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples at 52 ng/ml (fig 5d). Science (2019) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology CDH1 antibody (Cell Signalling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 2a). EMBO Mol Med (2019) ncbi
rabbit monoclonal (24E10)
  • mass cytometry; human; loading ...; fig 3a
Cell Signaling Technology CDH1 antibody (Cell Signaling Technologies, 3195) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 1b, 4d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195s) was used in western blot on human samples at 1:1000 (fig 1b, 4d). Nat Commun (2019) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195S) was used in western blot on human samples at 1:1000 (fig 3a). Biosci Rep (2018) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 3c
  • western blot; human; loading ...; fig s1f
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 3c) and in western blot on human samples (fig s1f). Cell Death Differ (2019) ncbi
rabbit monoclonal (24E10)
  • other; human; loading ...; fig 4c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3b). J Cell Mol Med (2018) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 1a). Mol Med Rep (2018) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 6g
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 6g). Biol Reprod (2018) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3c). Cancer Res (2018) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 3a2
Cell Signaling Technology CDH1 antibody (Cell Signalling, 24E10) was used in immunohistochemistry on human samples (fig 3a2). Stem Cells Int (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 3b
Cell Signaling Technology CDH1 antibody (CST, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b). Life Sci (2018) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...
In order to research a paradigm for generation of all major ectodermal lineages from human pluripotent stem cells, Cell Signaling Technology CDH1 antibody (Cell Signaling Technologies, 3195) was used in immunocytochemistry on human samples . Cell Stem Cell (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2j
In order to investigate the oncogenic effect of miR-210-3p in prostate cancer and bone metastasis and its mechanism, Cell Signaling Technology CDH1 antibody (cell signalling, 3195) was used in western blot on human samples (fig 2j). Mol Cancer (2017) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 6b
  • western blot; human; loading ...; fig 6a
In order to study the effect of symplekin on cellular proliferation and dedifferentiation, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195S) was used in immunocytochemistry on human samples (fig 6b) and in western blot on human samples (fig 6a). Sci Rep (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7b
  • immunocytochemistry; human; loading ...; fig 6d
  • western blot; human; fig 6a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195s) was used in immunohistochemistry - paraffin section on human samples (fig 7b), in immunocytochemistry on human samples (fig 6d) and in western blot on human samples (fig 6a). EBioMedicine (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1g
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry - frozen section on mouse samples (fig 1g). Dev Biol (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
  • western blot; human; loading ...; fig s3a-b
In order to investigate the oncogenic functions of CHD4, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 6a) and in western blot on human samples (fig s3a-b). Cancer Cell (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:200; fig 2a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:200 (fig 2a). J Clin Invest (2017) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:250; fig 3c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on mouse samples at 1:250 (fig 3c). J Cell Biol (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:500; loading ...; fig 2a
In order to elucidate the mechanism of Pin1 overexpression in hepatocellular carcinoma, Cell Signaling Technology CDH1 antibody (Cell Signaling Technolog, 3195 S) was used in western blot on human samples at 1:500 (fig 2a). Sci Rep (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 5c
In order to identify genes that contribute to human papilloma virus-16 associated oropharyngeal cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 5c). Sci Rep (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on mouse samples at 1:1000 (fig 4b). Nat Commun (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 7b
In order to identify conditions in which low-passage ARPE-19 cells express genes specific to native human RPE cells, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 7b). Mol Vis (2017) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:100; fig 3b
In order to investigate how LACTB suppresses breast cancer cell growth, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples at 1:100 (fig 3b). Nature (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2g
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology CDH1 antibody (cell signalling, 3195) was used in western blot on human samples (fig 2g). Cell Death Dis (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 6d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 6d). Int J Mol Med (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2c
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4b
In order to show that induction p53 loss in Krt8(+) mammary luminal cells leads to their clonal expansion without directly affecting their luminal identity, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4b). Nat Commun (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig s2
In order to evaluate the physical and functional interaction of elongation factor, RNA polymerase II, 2 with retinoblastoma in prostate cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig s2). Neoplasia (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples . Neoplasia (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3d). Cell Rep (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 7a
  • immunohistochemistry - paraffin section; mouse; fig 6b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 7a) and in immunohistochemistry - paraffin section on mouse samples (fig 6b). Oncogene (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology CDH1 antibody (Cell signaling, 24E10) was used in western blot on human samples (fig 3e). Oncoimmunology (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5a). Biomed Pharmacother (2017) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 4d
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig 4d). Sci Rep (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 5c). Oncol Lett (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; loading ...; fig 5b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195p) was used in western blot on mouse samples (fig 5b). PLoS Genet (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 10
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 24E10) was used in western blot on human samples (fig 10). Oncotarget (2017) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:2000; fig 4b
  • western blot; human; 1:2000; loading ...; fig 1b
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195S) was used in immunocytochemistry on human samples at 1:2000 (fig 4b) and in western blot on human samples at 1:2000 (fig 1b). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4g). Cell Death Dis (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
In order to study the architecture of the mouse mammary gland using high-resolution 3D imaging, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). Breast Cancer Res (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; loading ...; fig 3f
In order to suggest that planar cell polarity signaling governs directed epithelial evaginations to form crypts for implantation in mice, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195s) was used in immunohistochemistry on mouse samples (fig 3f). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 5a). Oncotarget (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5b
In order to investigate the role of IL-1beta/caspase-1 signaling in bleomycin lung toxicity and in pleural mesothelial cell transformation, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 5b). Respir Res (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 6a
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 6a) and in western blot on human samples (fig 5c). Cell Cycle (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig s3e
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig s3e). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig s13b
In order to examine the expression and role of major facilitator super family domain containing 2a in liver regeneration, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s13b). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 1c
In order to examine the differentiation potential of adult mammary stem cells, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3,195) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1c). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6a
In order to demonstrate that SUSD2 inhibits migration, epithelial-to-mesenchymal transition, and mesothelial clearance of high-grade serous ovarian carcinomas, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 6a). Oncogenesis (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:200; loading ...; fig 7b
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 7a
In order to study mycobacterial granuloma formation using zebrafish, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry on human samples at 1:200 (fig 7b) and in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7a). Immunity (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig s1c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig s1c). PLoS ONE (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 3b
  • western blot; human; loading ...; fig s2a
  • western blot; mouse; fig s2a
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on human samples (fig 3b), in western blot on human samples (fig s2a) and in western blot on mouse samples (fig s2a). J Clin Invest (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 1
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology CDH1 antibody (cell signalling, 3195S) was used in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 1d). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig s1b
In order to elucidate the role of DUOX1 silencing in lung cancer development or progression, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig s1b). Oncogenesis (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2e
  • immunocytochemistry; human; 1:200; loading ...; fig 3e
  • western blot; human; 1:500; loading ...; fig 3d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2e), in immunocytochemistry on human samples at 1:200 (fig 3e) and in western blot on human samples at 1:500 (fig 3d). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; 1:2000; fig 3d
In order to report that CEACAM1 regulates the epithelial-mesenchymal transition via beta-catenin phosphorylation, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples at 1:2000 (fig 3d). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:400; loading ...; fig 2c
In order to study the role of RB1 in cancer cell proliferation., Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry on human samples at 1:400 (fig 2c). J Clin Invest (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; fig 6
In order to characterize the interaction between VAR2CSA and chondroitin sulfate proteoglycans, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:200 (fig 6). PLoS Pathog (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
  • western blot; mouse; loading ...; fig 6a
In order to assess the role of EphA2 signaling in mice with lipopolysaccharide-induced lung injury, Cell Signaling Technology CDH1 antibody (Cell Signaling Technologies, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c) and in western blot on mouse samples (fig 6a). Clin Sci (Lond) (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195P) was used in western blot on human samples (fig 2b). J Biol Chem (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:300; fig 2
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:300 (fig 2). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 2a
In order to report how PTEN alters breast cancer metastatic behavior, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 2a). Anticancer Res (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:500; fig 5
  • western blot; human; 1:1000; fig 3
In order to analyze the mediation of the STAT3 signaling pathway by sinomenine that inhibits A549 human lung cancer cell invasion, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:500 (fig 5) and in western blot on human samples at 1:1000 (fig 3). Oncol Lett (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 2b
In order to demonstrate that Rock regulates Hippo signaling and ensures the correct subcellular localization Amot in outer cells, Cell Signaling Technology CDH1 antibody (Cell Signalling, 3195) was used in immunohistochemistry on mouse samples at 1:500 (fig 2b). Reprod Biomed Online (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 1
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 1). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 2c
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig 2c). J Proteomics (2017) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 4a). Drug Des Devel Ther (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; loading ...; fig 4a
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples (fig 4a). Oncogene (2017) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; fig s3
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig s3). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 5m
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 5m). Sci Rep (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1b
In order to explore the interaction between ARF and MMP7 in prostate cancer, Cell Signaling Technology CDH1 antibody (cell signalling, 24E10) was used in immunohistochemistry on mouse samples at 1:400 (fig 1b). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:500; loading ...; fig 2e
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, Cell Signaling Technology CDH1 antibody (cell signalling, 3195) was used in immunocytochemistry on human samples at 1:500 (fig 2e). Science (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; 1:500; fig s7
In order to analyze preservation of epithelial polarity and epithelial barrier by alix-mediated assembly of the actomyosin-tight junction polarity complex, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on mouse samples at 1:500 (fig s7). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 2c) and in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology CDH1 antibody (Cell Signaling Tech, 3195S) was used in western blot on human samples at 1:1000 (fig 1). BMC Biol (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:6000; loading ...; fig 1d
Cell Signaling Technology CDH1 antibody (cell signalling, 3195) was used in western blot on human samples at 1:6000 (fig 1d). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1d
In order to elucidate how E-cadherin, tight junctions, and the epithelial-to-mesenchymal transition regulates hepatitis C virus entry, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples (fig 1a) and in western blot on human samples (fig 1d). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; 1:1000; fig 7
In order to assess the transiently formed junctional nexuses during post-natal mammary gland development by E-cadherins, connexins, beta-catenin, and claudin-7, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195s) was used in western blot on mouse samples at 1:1000 (fig 7). Dev Biol (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 8a
In order to determine how C3G controls tumorigenesis, Cell Signaling Technology CDH1 antibody (cell signaling, 3195S) was used in immunohistochemistry - paraffin section on human samples (fig 8a). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 3b
In order to demonstrate that miR-150 is a novel Wnt effector in colorectal cells, Cell Signaling Technology CDH1 antibody (CST, 3195S) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:3000; loading ...; fig 5b
In order to investigate the impact of protein arginine methyltransferase 5 in lung and breast cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:3000 (fig 5b). Oncogene (2017) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
Cell Signaling Technology CDH1 antibody (Cell Signaling Tech, 3195) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3g
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3g). FEBS Open Bio (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1
  • western blot; mouse; 1:1000; fig 1
In order to investigate regulation of actin cytoskeleton organization by Yes-associated protein impacting adherens junction assembly, Cell Signaling Technology CDH1 antibody (CST, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1) and in western blot on mouse samples at 1:1000 (fig 1). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 7a
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 7a). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 6e
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunocytochemistry on human samples (fig 6e). Sci Rep (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 5d
Cell Signaling Technology CDH1 antibody (cell signalling, 3195P) was used in western blot on human samples at 1:1000 (fig 5d). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 6f
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6f). Int J Biol Sci (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig s3
In order to analyze the rescue of intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation due to ERK5 signaling, Cell Signaling Technology CDH1 antibody (Cell signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples (fig s3). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4a
In order to study the role of Skp2 in paclitaxel-resistant prostate cancer cells, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4a). Oncol Rep (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5f
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 5f). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology CDH1 antibody (Cell Signalling, 3195) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 23E10) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3). elife (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 4
In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 4). Int J Mol Sci (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:2000; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:2000 (fig 3). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 4
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:500; tbl 2
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). PLoS ONE (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study a decrease in glutathione and SOX17 and toxin biliastresone that causes mouse extrahepatic cholangiocyte damage and fibrosis, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10 3195S) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Hepatology (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 5). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Endocrinology (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:250; fig 7
In order to maintain adherens junction stability and tension by neogenin recruitment of the WAVE regulatory complex, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples at 1:250 (fig 7). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 4c). Int J Biol Sci (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 3
In order to utilize a model of metastatic HPV+ oropharyngeal squamous cell carcinoma to displays heterogeneity in tumor metastasis, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 3). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
  • immunocytochemistry; mouse; loading ...; fig 4g
  • western blot; mouse; loading ...; fig 4f
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195S) was used in immunocytochemistry on human samples (fig 4b), in western blot on human samples (fig 4a), in immunocytochemistry on mouse samples (fig 4g) and in western blot on mouse samples (fig 4f). Nat Commun (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 1
In order to identify cleavage sites for helicobacter pylori HtrA with E-cadherin signature motifs, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; mouse; 1:250; fig 1
In order to learn the origin of development of lung macrophage diversity, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195S) was used in immunohistochemistry - frozen section on mouse samples at 1:250 (fig 1). Development (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 2
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on human samples at 1:1000 (fig 2) and in western blot on mouse samples at 1:1000 (fig 6). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:200; fig 1c
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples at 1:200 (fig 1c) and in western blot on human samples at 1:1000 (fig s3b). Science (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 4d
Cell Signaling Technology CDH1 antibody (Cell signalling technology, 3195S) was used in western blot on human samples (fig 4d). Nucleic Acids Res (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 3d). Sci Rep (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4b
In order to identify factors that contribute to the epithelial-mesenchymal transition using 16 colorectal cancer cell lines, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 4b). Cancer Sci (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 4
In order to study the interaction between EGFR and delta catenin, which leads to delta catenin phosphorylation and EGFR signaling enhancement, Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig 4). Sci Rep (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 6
  • immunohistochemistry; human; fig 4
  • western blot; human; fig 6
In order to elucidate the role of BCORL1 as an independent prognostic marker and a contributor to cell migrations and invasion in human hepatocellular carcinoma, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples (fig 6), in immunohistochemistry on human samples (fig 4) and in western blot on human samples (fig 6). BMC Cancer (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 3
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Oncogene (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 2
  • western blot; human; fig 1
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 2) and in western blot on human samples (fig 1). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - frozen section; scFv; fig 2E
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry - frozen section on scFv samples (fig 2E). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:75; fig 4c
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry on human samples at 1:75 (fig 4c). Histopathology (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:100; fig 3
In order to study regulation of adhesion and cell migration by recruitment to the leading edge by human phosphatase CDC14A, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:100 (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:5000; fig 4
In order to determine the mechanisms of resistance to the pan-HER family inhibitor AZD8931, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 4). Dis Model Mech (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse; 1:100; fig 4
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig s3
  • western blot; human; fig 6
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig s3) and in western blot on human samples (fig 6). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 4h
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 4h). Int J Oncol (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 1b
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:1000 (fig 1b). Endocr Relat Cancer (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:500; fig 4
In order to analyze high-grade serous epithelial ovarian cancer cell lines that show sporadic and hereditary disease and the molecular diversity, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples at 1:500 (fig 4). Genes Cancer (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 4
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Oncogene (2016) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; fig 5
  • western blot; human; 1:200; fig 5
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples at 1:200 (fig 5) and in western blot on human samples at 1:200 (fig 5). Oncotarget (2016) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to analyze a model for ductal pancreatic cancer and drug screening, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Nat Med (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; fig 6
  • western blot; human; fig 1
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on human samples (fig 6) and in western blot on human samples (fig 1). Oncotarget (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5). Mol Cancer (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:200; loading ...; fig s3c
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195S) was used in immunocytochemistry on human samples at 1:200 (fig s3c). J Cell Biol (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; fig 2b
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on mouse samples (fig 2b). Stem Cells Dev (2016) ncbi
rabbit monoclonal (24E10)
  • flow cytometry; human; 1:200; tbl 4
  • immunocytochemistry; human; 1:500; tbl 4
  • western blot; human; 1:1000; tbl 4
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in flow cytometry on human samples at 1:200 (tbl 4), in immunocytochemistry on human samples at 1:500 (tbl 4) and in western blot on human samples at 1:1000 (tbl 4). Sci Rep (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology , #3195) was used in western blot on human samples at 1:1000 (fig 4). Int J Cancer (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3). Nature (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 3a
In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3a). Oncogene (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3d). Dig Dis Sci (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 8
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 8). Neuroendocrinology (2016) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 1
Cell Signaling Technology CDH1 antibody (Cell Signal, 24E10) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse; 1:4000; fig 1
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on mouse samples at 1:4000 (fig 1). PLoS ONE (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:1000; fig 3
In order to examine the effects of vitamin D on anaplastic thyroid cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples at 1:1000 (fig 3). Cancer Lett (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human
In order to study OGR1-mediated, pH-dependent signaling pathways in intestinal epithelial cells, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples . Am J Physiol Gastrointest Liver Physiol (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology CDH1 antibody (CST, #3195) was used in western blot on human samples . Oncol Rep (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
Cell Signaling Technology CDH1 antibody (Sigma, 3195) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Int J Mol Med (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; 1:100; loading ...; tbl 1
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195S) was used in immunocytochemistry on human samples at 1:100 (tbl 1). Oncotarget (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 1
Cell Signaling Technology CDH1 antibody (Cell Signaling Tech, 3195s) was used in western blot on human samples (fig 1). Int J Mol Med (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 5
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5). Nat Commun (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 6
  • western blot; mouse; 1:1000; fig 6
In order to assess the effects of Shenling Baizhu San on colitis-associated colorectal cancer, Cell Signaling Technology CDH1 antibody (CST, 24E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6) and in western blot on mouse samples at 1:1000 (fig 6). BMC Complement Altern Med (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:400; fig 6
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 24E10) was used in immunocytochemistry on mouse samples at 1:400 (fig 6). BMC Dev Biol (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:400; fig 4
  • western blot; human; 1:1000; fig 4
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry on human samples at 1:400 (fig 4) and in western blot on human samples at 1:1000 (fig 4). Cancer Lett (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195P) was used in western blot on human samples (fig 3). Int J Gynecol Cancer (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; mouse
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunohistochemistry on mouse samples . PLoS ONE (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 5). Mol Oncol (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 3
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on human samples (fig 3). Ann Surg Oncol (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 6
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 6). Mol Cell Proteomics (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 4
In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples (fig 4). Oncogene (2015) ncbi
rabbit monoclonal (24E10)
  • flow cytometry; human
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3b
Cell Signaling Technology CDH1 antibody (Cell signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3b). Int J Cancer (2015) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:100
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 24E10) was used in immunohistochemistry on human samples at 1:100. BMC Vet Res (2014) ncbi
rabbit monoclonal (24E10)
  • flow cytometry; mouse; 1:50; fig 9
In order to assess MTV-Wnt1 tumors and how Wnt5a suppresses tumor formation and redirects tumor phenotype, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in flow cytometry on mouse samples at 1:50 (fig 9). PLoS ONE (2014) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:200
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on mouse samples at 1:200. J Clin Invest (2014) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry; human; 1:400; fig 4
In order to determine the effects of targeting the VEGF and c-met pathways in clear cell renal cell carcinoma models, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry on human samples at 1:400 (fig 4). Mol Cancer Ther (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human; fig 4
In order to demonstrate the transcriptional repression of ANXA2 by ERG in prostate epithelial cells and discuss how this interaction relates to prostate cancer, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunocytochemistry on human samples (fig 4). Mol Cancer Res (2015) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; human
  • western blot; human
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 4b). Mol Biol Cell (2014) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). J Biol Chem (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology CDH1 antibody (Cell Signalling Technology, 3195S) was used in western blot on human samples . Cell Prolif (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Cell Signaling Technology CDH1 antibody (Cell Signaling, 3195) was used in western blot on human samples . Cancer Cell (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology CDH1 antibody (Cell Signaling technology, 3195P) was used in western blot on human samples . PLoS ONE (2014) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; human; 1:600
  • western blot; human; 1:800
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on human samples at 1:600 and in western blot on human samples at 1:800. Urol Oncol (2014) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; 1:100
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunocytochemistry on mouse samples at 1:100. Exp Eye Res (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology CDH1 antibody (Cell Signal Technology, 24E10) was used in western blot on human samples . Biochim Biophys Acta (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human; fig 5b
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on human samples (fig 5b). Oncotarget (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples . PLoS ONE (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
In order to show that uPAR regulates nasopharyngeal carcinoma NPC progression, Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in western blot on human samples . Cell Cycle (2014) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; 1:500
In order to study the ability of miRNA-100 to promote epithelial-to-mesenchymal transition but also to inhibit mammary tumor cell invasiveness and tumorogenesis, Cell Signaling Technology CDH1 antibody (Cell signaling Technology, 3195) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. PLoS Genet (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; human
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 24E10) was used in western blot on human samples . Br J Cancer (2014) ncbi
rabbit monoclonal (24E10)
  • immunocytochemistry; mouse; fig 6h
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in immunocytochemistry on mouse samples (fig 6h). PLoS ONE (2014) ncbi
rabbit monoclonal (24E10)
  • western blot; mouse
Cell Signaling Technology CDH1 antibody (Cell Signaling, 24E10) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse
Cell Signaling Technology CDH1 antibody (Cell signaling, 24E10) was used in immunohistochemistry - paraffin section on mouse samples . EMBO Mol Med (2013) ncbi
rabbit monoclonal (24E10)
  • immunohistochemistry - paraffin section; mouse; fig 3
Cell Signaling Technology CDH1 antibody (Cell Signaling Technology, 3195) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). PLoS Genet (2013) ncbi
Articles Reviewed
  1. Fan M, Zou Y, He P, Zhang S, Sun X, Li C. Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis. Biosci Rep. 2019;: pubmed publisher
  2. Choi J, Zhong X, McAlpine W, Liao T, Zhang D, Fang B, et al. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science. 2019;364: pubmed publisher
  3. Singh R, Peng S, Viswanath P, Sambandam V, Shen L, Rao X, et al. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis. EMBO Mol Med. 2019;: pubmed publisher
  4. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  5. Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang L, et al. Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat Commun. 2019;10:1637 pubmed publisher
  6. Degen M, Wiederkehr A, La Scala G, Carmann C, Schnyder I, Katsaros C. Keratinocytes Isolated From Individual Cleft Lip/Palate Patients Display Variations in Their Differentiation Potential in vitro. Front Physiol. 2018;9:1703 pubmed publisher
  7. Wang X, Du C, He X, Deng X, He Y, Zhou X. MiR-4463 inhibits the migration of human aortic smooth muscle cells by AMOT. Biosci Rep. 2018;38: pubmed publisher
  8. Zhu Y, Qu C, Hong X, Jia Y, Lin M, Luo Y, et al. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ. 2019;26:306-320 pubmed publisher
  9. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  10. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
  11. Park G, Kim D. Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway. Mol Med Rep. 2018;17:3563-3574 pubmed publisher
  12. Liu S, Li X, Lin Z, Su L, Yan S, Zhao B, et al. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis. Cancer Lett. 2018;416:11-23 pubmed publisher
  13. El Zowalaty A, Li R, Chen W, Ye X. Seipin deficiency leads to increased endoplasmic reticulum stress and apoptosis in mammary gland alveolar epithelial cells during lactation. Biol Reprod. 2018;98:570-578 pubmed publisher
  14. Yu R, Longo J, van Leeuwen J, Mullen P, Ba Alawi W, Haibe Kains B, et al. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins. Cancer Res. 2018;78:1347-1357 pubmed publisher
  15. Spitzhorn L, Rahman M, Schwindt L, Ho H, Wruck W, Bohndorf M, et al. Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections. Stem Cells Int. 2017;2017:5932706 pubmed publisher
  16. Ma Q, Wang Y, Zhang T, Zuo W. Notch-mediated Sox9+ cell activation contributes to kidney repair after partial nephrectomy. Life Sci. 2018;193:104-109 pubmed publisher
  17. Tchieu J, Zimmer B, Fattahi F, Amin S, Zeltner N, Chen S, et al. A Modular Platform for Differentiation of Human PSCs into All Major Ectodermal Lineages. Cell Stem Cell. 2017;21:399-410.e7 pubmed publisher
  18. Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, et al. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-?B signaling pathway. Mol Cancer. 2017;16:117 pubmed publisher
  19. Zhang C, Mao H, Cao Y. Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner. Sci Rep. 2017;7:3769 pubmed publisher
  20. Liang X, Yuan X, Yu J, Wu Y, Li K, Sun C, et al. Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes. EBioMedicine. 2017;21:104-116 pubmed publisher
  21. Logan C, Rajakaruna S, Bowen C, Radice G, Robinson M, Menko A. N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis. Dev Biol. 2017;428:118-134 pubmed publisher
  22. Xia L, Huang W, Bellani M, Seidman M, Wu K, Fan D, et al. CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes. Cancer Cell. 2017;31:653-668.e7 pubmed publisher
  23. Giroux V, Lento A, Islam M, Pitarresi J, Kharbanda A, Hamilton K, et al. Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration. J Clin Invest. 2017;127:2378-2391 pubmed publisher
  24. Riemer P, Rydenfelt M, Marks M, van Eunen K, Thedieck K, Herrmann B, et al. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids. J Cell Biol. 2017;216:1567-1577 pubmed publisher
  25. Zhao H, Zhang L, Zhang Y, Zhao L, Wan Q, Wang B, et al. Calmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells. Oncotarget. 2017;8:36383-36398 pubmed publisher
  26. Yan X, Zhu Z, Xu S, Yang L, Liao X, Zheng M, et al. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep. 2017;7:45915 pubmed publisher
  27. Kannan A, Hertweck K, Philley J, Wells R, Dasgupta S. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer. Sci Rep. 2017;7:46102 pubmed publisher
  28. Ahmed S, Macara I. The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Nat Commun. 2017;8:14867 pubmed publisher
  29. Samuel W, Jaworski C, Postnikova O, Kutty R, Duncan T, Tan L, et al. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis. 2017;23:60-89 pubmed
  30. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  31. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  32. Li X, Liu W, Chen X, Wang Y, Shi D, Zhang H, et al. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer. Int J Mol Med. 2017;39:927-935 pubmed publisher
  33. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  34. Tao L, Xiang D, Xie Y, Bronson R, Li Z. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours. Nat Commun. 2017;8:14431 pubmed publisher
  35. Qiu X, Pascal L, Song Q, Zang Y, Ai J, O Malley K, et al. Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. Neoplasia. 2017;19:207-215 pubmed publisher
  36. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  37. Gonzalez M, Martin E, Anwar T, Arellano Garcia C, Medhora N, Lama A, et al. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth. Cell Rep. 2017;18:1215-1228 pubmed publisher
  38. He Y, Northey J, Pelletier A, Kos Z, Meunier L, Haibe Kains B, et al. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer. Oncogene. 2017;36:3490-3503 pubmed publisher
  39. Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, et al. The pattern of hMENA isoforms is regulated by TGF-?1 in pancreatic cancer and may predict patient outcome. Oncoimmunology. 2016;5:e1221556 pubmed publisher
  40. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed publisher
  41. Das S, Jackson W, Prasain J, Hanna A, Bailey S, Tucker J, et al. Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling. Sci Rep. 2017;7:40773 pubmed publisher
  42. Zhang Y, An J, Lv W, Lou T, Liu Y, Kang W. miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin. Oncol Lett. 2016;12:5163-5169 pubmed publisher
  43. Jiang C, Diao F, Sang Y, Xu N, Zhu R, Wang X, et al. GGPP-Mediated Protein Geranylgeranylation in Oocyte Is Essential for the Establishment of Oocyte-Granulosa Cell Communication and Primary-Secondary Follicle Transition in Mouse Ovary. PLoS Genet. 2017;13:e1006535 pubmed publisher
  44. Boylan K, Buchanan P, Manion R, Shukla D, Braumberger K, Bruggemeyer C, et al. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget. 2017;8:9717-9738 pubmed publisher
  45. Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, et al. MicroRNA-182 targets SMAD7 to potentiate TGF?-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 2016;7:13884 pubmed publisher
  46. Amoroso M, Matassa D, Agliarulo I, Avolio R, Lu H, Sisinni L, et al. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis. 2016;7:e2522 pubmed publisher
  47. Lloyd Lewis B, Davis F, Harris O, Hitchcock J, Lourenco F, Pasche M, et al. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods. Breast Cancer Res. 2016;18:127 pubmed
  48. Yuan J, Cha J, Deng W, Bartos A, Sun X, Ho H, et al. Planar cell polarity signaling in the uterus directs appropriate positioning of the crypt for embryo implantation. Proc Natl Acad Sci U S A. 2016;113:E8079-E8088 pubmed
  49. He X, Liu Z, Xia Y, Xu J, Lv G, Wang L, et al. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs. Oncotarget. 2017;8:1247-1261 pubmed publisher
  50. Burgy O, Bellaye P, Causse S, Beltramo G, Wettstein G, Boutanquoi P, et al. Pleural inhibition of the caspase-1/IL-1? pathway diminishes profibrotic lung toxicity of bleomycin. Respir Res. 2016;17:162 pubmed
  51. Bryson B, Junk D, Cipriano R, Jackson M. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle. 2017;16:319-334 pubmed publisher
  52. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  53. Pu W, Zhang H, Huang X, Tian X, He L, Wang Y, et al. Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration. Nat Commun. 2016;7:13369 pubmed publisher
  54. Davis F, Lloyd Lewis B, Harris O, Kozar S, Winton D, Muresan L, et al. Single-cell lineage tracing in the mammary gland reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nat Commun. 2016;7:13053 pubmed publisher
  55. Sheets J, Iwanicki M, Liu J, Howitt B, Hirsch M, Gubbels J, et al. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance. Oncogenesis. 2016;5:e264 pubmed publisher
  56. Cronan M, Beerman R, ROSENBERG A, Saelens J, Johnson M, Oehlers S, et al. Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection. Immunity. 2016;45:861-876 pubmed publisher
  57. Zhao X, Li L, Wang X, Fu R, Lv Y, Jin W, et al. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0164752 pubmed publisher
  58. Shenoy A, Jin Y, Luo H, Tang M, Pampo C, Shao R, et al. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells. J Clin Invest. 2016;126:4174-4186 pubmed publisher
  59. Liu B, Dong H, Lin X, Yang X, Yue X, Yang J, et al. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion. Oncotarget. 2016;7:82411-82423 pubmed publisher
  60. Little A, Sham D, Hristova M, Danyal K, Heppner D, Bauer R, et al. DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties. Oncogenesis. 2016;5:e261 pubmed publisher
  61. Cao R, Meng Z, Liu T, Wang G, Qian G, Cao T, et al. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 2016;7:72941-72960 pubmed publisher
  62. Wegwitz F, Lenfert E, Gerstel D, von Ehrenstein L, Einhoff J, Schmidt G, et al. CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. Oncotarget. 2016;7:63730-63746 pubmed publisher
  63. Jones R, Robinson T, Liu J, Shrestha M, Voisin V, Ju Y, et al. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. J Clin Invest. 2016;126:3739-3757 pubmed publisher
  64. Ayres Pereira M, Mandel Clausen T, Pehrson C, Mao Y, Resende M, Daugaard M, et al. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathog. 2016;12:e1005831 pubmed publisher
  65. Hong J, Shin M, Douglas I, Chung K, Kim E, Jung J, et al. Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. Clin Sci (Lond). 2016;130:1993-2003 pubmed
  66. Liu L, Phua Y, Lee R, Ma X, Jenkins Y, Novy K, et al. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. J Biol Chem. 2016;291:21571-21583 pubmed
  67. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  68. Chiang K, Hsu S, Lin S, Yeh C, Pang J, Wang S, et al. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model. Anticancer Res. 2016;36:3997-4005 pubmed
  69. Jiang S, Gao Y, Hou W, Liu R, Qi X, Xu X, et al. Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway. Oncol Lett. 2016;12:1380-1386 pubmed
  70. Mihajlovic A, Bruce A. Rho-associated protein kinase regulates subcellular localisation of Angiomotin and Hippo-signalling during preimplantation mouse embryo development. Reprod Biomed Online. 2016;33:381-90 pubmed publisher
  71. Pijuan Galitó S, Tamm C, Schuster J, Sobol M, Forsberg L, Merry C, et al. Human serum-derived protein removes the need for coating in defined human pluripotent stem cell culture. Nat Commun. 2016;7:12170 pubmed publisher
  72. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  73. Yang S, Tsai C, Pan Y, Yeh C, Pang J, Takano M, et al. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016;10:1995-2002 pubmed publisher
  74. Liang Y, Zhu F, Zhang H, Chen D, Zhang X, Gao Q, et al. Conditional ablation of TGF-? signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model. Sci Rep. 2016;6:29479 pubmed publisher
  75. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  76. Hatem R, El Botty R, Chateau Joubert S, Servely J, Labiod D, de Plater L, et al. Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers. Oncotarget. 2016;7:48206-48219 pubmed publisher
  77. Stock K, Estrada M, Vidic S, Gjerde K, Rudisch A, Santo V, et al. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep. 2016;6:28951 pubmed publisher
  78. Xie Y, Lu W, Liu S, Yang Q, Goodwin J, Sathyanarayana S, et al. MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. Oncotarget. 2016;7:47609-47619 pubmed publisher
  79. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  80. Campos Y, Qiu X, Gomero E, Wakefield R, Horner L, Brutkowski W, et al. Alix-mediated assembly of the actomyosin-tight junction polarity complex preserves epithelial polarity and epithelial barrier. Nat Commun. 2016;7:11876 pubmed publisher
  81. Helmke C, Raab M, Rodel F, Matthess Y, Oellerich T, Mandal R, et al. Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8. Cell Res. 2016;26:914-34 pubmed publisher
  82. Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, et al. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit. Oncotarget. 2016;7:45414-45428 pubmed publisher
  83. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  84. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  85. Li Q, Sodroski C, Lowey B, Schweitzer C, Cha H, Zhang F, et al. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proc Natl Acad Sci U S A. 2016;113:7620-5 pubmed publisher
  86. Dianati E, Poiraud J, Weber Ouellette A, Plante I. Connexins, E-cadherin, Claudin-7 and ?-catenin transiently form junctional nexuses during the post-natal mammary gland development. Dev Biol. 2016;416:52-68 pubmed publisher
  87. Priego N, Arechederra M, Sequera C, Bragado P, Vázquez Carballo A, Gutierrez Uzquiza A, et al. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38? activation, while it impairs tumor growth through p38?-independent mechanisms. Oncotarget. 2016;7:45060-45078 pubmed publisher
  88. Guo Y, Wang L, Li B, Xu H, Yang J, Zheng L, et al. Wnt/?-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling. Oncotarget. 2016;7:42513-42526 pubmed publisher
  89. Chen H, Lorton B, Gupta V, Shechter D. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression. Oncogene. 2017;36:373-386 pubmed publisher
  90. Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35:88 pubmed publisher
  91. Qi J, Li T, Bian H, Li F, Ju Y, Gao S, et al. SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis. FEBS Open Bio. 2016;6:326-37 pubmed publisher
  92. Bai H, Zhu Q, Surcel A, Luo T, Ren Y, Guan B, et al. Yes-associated protein impacts adherens junction assembly through regulating actin cytoskeleton organization. Am J Physiol Gastrointest Liver Physiol. 2016;311:G396-411 pubmed publisher
  93. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  94. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  95. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed publisher
  96. He F, Wei L, Luo W, Liao Z, Li B, Zhou X, et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget. 2016;7:37000-37012 pubmed publisher
  97. Petit F, Deng C, Jamin S. Partial Müllerian Duct Retention in Smad4 Conditional Mutant Male Mice. Int J Biol Sci. 2016;12:667-76 pubmed publisher
  98. de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed publisher
  99. Yang Y, Lu Y, Wang L, Mizokami A, Keller E, Zhang J, et al. Skp2 is associated with paclitaxel resistance in prostate cancer cells. Oncol Rep. 2016;36:559-66 pubmed publisher
  100. Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
  101. Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, et al. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer. Sci Rep. 2016;6:25447 pubmed publisher
  102. Rolo A, Savery D, Escuin S, de Castro S, Armer H, Munro P, et al. Regulation of cell protrusions by small GTPases during fusion of the neural folds. elife. 2016;5:e13273 pubmed publisher
  103. Chiang K, Yeh T, Chen S, Pang J, Yeh C, Hsu J, et al. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 2016;17: pubmed publisher
  104. Lin S, Kao C, Lee H, Creighton C, Ittmann M, Tsai S, et al. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer. Nat Commun. 2016;7:11418 pubmed publisher
  105. Leung C, Mak W, Kai A, Chan K, Lee T, Ng I, et al. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/?-catenin signaling. Oncotarget. 2016;7:29371-86 pubmed publisher
  106. Sato K, Suda K, Shimizu S, Sakai K, Mizuuchi H, Tomizawa K, et al. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression. PLoS ONE. 2016;11:e0154186 pubmed publisher
  107. Chan C, Chu H, Zhang A, Leung L, Sze K, Kao R, et al. Hemagglutinin of influenza A virus binds specifically to cell surface nucleolin and plays a role in virus internalization. Virology. 2016;494:78-88 pubmed publisher
  108. Waisbourd Zinman O, Koh H, Tsai S, Lavrut P, Dang C, Zhao X, et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 2016;64:880-93 pubmed publisher
  109. Wang Z, Xie J, Yan M, Wang J, Wang X, Zhang J, et al. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma. Oncotarget. 2016;7:26765-79 pubmed publisher
  110. Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed publisher
  111. Lee N, Fok K, White A, Wilson N, O Leary C, Cox H, et al. Neogenin recruitment of the WAVE regulatory complex maintains adherens junction stability and tension. Nat Commun. 2016;7:11082 pubmed publisher
  112. Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y, et al. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 2016;12:381-8 pubmed publisher
  113. Vermeer D, Coppock J, Zeng E, Lee K, Spanos W, Onken M, et al. Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis. Oncotarget. 2016;7:24194-207 pubmed publisher
  114. Yin S, Fan Y, Zhang H, Zhao Z, Hao Y, Li J, et al. Differential TGF? pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun. 2016;7:11012 pubmed publisher
  115. Schmidt T, Perna A, Fugmann T, Böhm M, Jan Hiss -, Haller S, et al. Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA. Sci Rep. 2016;6:23264 pubmed publisher
  116. Ji X, Liu Y, Hurd R, Wang J, Fitzmaurice B, Nishina P, et al. Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Invest Ophthalmol Vis Sci. 2016;57:877-88 pubmed publisher
  117. Hirth S, Bühler A, Bührdel J, Rudeck S, Dahme T, Rottbauer W, et al. Paxillin and Focal Adhesion Kinase (FAK) Regulate Cardiac Contractility in the Zebrafish Heart. PLoS ONE. 2016;11:e0150323 pubmed publisher
  118. Tan S, Krasnow M. Developmental origin of lung macrophage diversity. Development. 2016;143:1318-27 pubmed publisher
  119. Shukla S, Schmidt J, Goldfarb K, Cech T, Parker R. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects. Nat Struct Mol Biol. 2016;23:286-92 pubmed publisher
  120. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  121. Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher
  122. Chang H, Liu Y, Xue M, Liu H, Du S, Zhang L, et al. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition. Nucleic Acids Res. 2016;44:2514-27 pubmed publisher
  123. Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, et al. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Sci Rep. 2016;6:22090 pubmed publisher
  124. Jung B, Padula D, Burtscher I, Landerer C, Lutter D, Theis F, et al. Pitchfork and Gprasp2 Target Smoothened to the Primary Cilium for Hedgehog Pathway Activation. PLoS ONE. 2016;11:e0149477 pubmed publisher
  125. Matsuda Y, Miura K, Yamane J, Shima H, Fujibuchi W, Ishida K, et al. SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer. Cancer Sci. 2016;107:619-28 pubmed publisher
  126. He Y, Ryu T, Shrestha N, Yuan T, Kim H, Shrestha H, et al. Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling. Sci Rep. 2016;6:21207 pubmed publisher
  127. Yin G, Liu Z, Wang Y, Dou C, Li C, Yang W, et al. BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma. BMC Cancer. 2016;16:103 pubmed publisher
  128. Du L, Chen X, Cao Y, Lu L, Zhang F, Bornstein S, et al. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling. Oncogene. 2016;35:4641-52 pubmed publisher
  129. Li J, Pan Q, Rowan P, Trotter T, Peker D, Regal K, et al. Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells. Oncotarget. 2016;7:11299-309 pubmed publisher
  130. Bühler A, Kustermann M, Bummer T, Rottbauer W, Sandri M, Just S. Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish. Int J Mol Sci. 2016;17: pubmed publisher
  131. Cheung K, Padmanaban V, Silvestri V, Schipper K, Cohen J, Fairchild A, et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci U S A. 2016;113:E854-63 pubmed publisher
  132. Guedj N, Vaquero J, Clapéron A, Mergey M, Chrétien Y, Paradis V, et al. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin. Histopathology. 2016;69:211-21 pubmed publisher
  133. Chen N, Uddin B, Voit R, Schiebel E. Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion. Proc Natl Acad Sci U S A. 2016;113:990-5 pubmed publisher
  134. Creedon H, Balderstone L, Muir M, Balla J, Gómez Cuadrado L, Tracey N, et al. Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer. Dis Model Mech. 2016;9:131-40 pubmed publisher
  135. Benitz S, Regel I, Reinhard T, Popp A, Schäffer I, Raulefs S, et al. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells. Oncotarget. 2016;7:11424-33 pubmed publisher
  136. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  137. Yan L, Liu Y, Xiang J, Wu Q, Xu L, Luo X, et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 2016;48:471-84 pubmed publisher
  138. Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, et al. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer. 2016;23:147-59 pubmed publisher
  139. Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al. Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed
  140. Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N, et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91 pubmed publisher
  141. Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, et al. STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling. Oncogene. 2016;35:4388-98 pubmed publisher
  142. Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, et al. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget. 2016;7:293-307 pubmed publisher
  143. Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364-71 pubmed publisher
  144. Qin W, Li C, Zheng W, Guo Q, Zhang Y, Kang M, et al. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells. Oncotarget. 2015;6:39839-54 pubmed publisher
  145. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed publisher
  146. Dong W, Zhang X, Liu W, Chen Y, Huang J, Austin E, et al. A conserved polybasic domain mediates plasma membrane targeting of Lgl and its regulation by hypoxia. J Cell Biol. 2015;211:273-86 pubmed publisher
  147. Jiang Y, Du M, Wu M, Zhu Y, Zhao X, Cao X, et al. Phosphatidic Acid Improves Reprogramming to Pluripotency by Reducing Apoptosis. Stem Cells Dev. 2016;25:43-54 pubmed publisher
  148. Nath A, Li I, Roberts L, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep. 2015;5:14752 pubmed publisher
  149. Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, et al. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer. Int J Cancer. 2016;138:1207-19 pubmed publisher
  150. Werner A, Iwasaki S, McGourty C, Medina Ruiz S, Teerikorpi N, Fedrigo I, et al. Cell-fate determination by ubiquitin-dependent regulation of translation. Nature. 2015;525:523-7 pubmed publisher
  151. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
  152. Kuang X, Zhu J, Peng Z, Wang J, Chen Z. Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Dig Dis Sci. 2016;61:489-500 pubmed publisher
  153. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  154. Zhang Y, Wei X, Liang Y, Chen W, Zhang F, Bai J, et al. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. PLoS ONE. 2015;10:e0135851 pubmed publisher
  155. Mehrabian M, Brethour D, Wang H, Xi Z, Rogaeva E, Schmitt Ulms G. The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis. PLoS ONE. 2015;10:e0133741 pubmed publisher
  156. Chiang K, Kuo S, Chen C, Ng S, Lin S, Yeh C, et al. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Lett. 2015;369:76-85 pubmed publisher
  157. He S, Zhao Z, Yang Y, O Connell D, Zhang X, Oh S, et al. Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers. Nat Commun. 2015;6:7839 pubmed publisher
  158. de Vallière C, Vidal S, Clay I, Jurisic G, Tcymbarevich I, Lang S, et al. The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment. Am J Physiol Gastrointest Liver Physiol. 2015;309:G475-90 pubmed publisher
  159. Nagahara T, Shiraha H, Sawahara H, Uchida D, Takeuchi Y, Iwamuro M, et al. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells. Oncol Rep. 2015;34:1169-77 pubmed publisher
  160. Zhao L, Liu S, Che X, Hou K, Ma Y, Li C, et al. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med. 2015;36:645-52 pubmed publisher
  161. Huang R, Kuay K, Tan T, Asad M, Tang H, Ng A, et al. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120). Oncotarget. 2015;6:22098-113 pubmed
  162. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  163. Sato S, Kawamata Y, Takahashi A, Imai Y, Hanyu A, Okuma A, et al. Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice. Nat Commun. 2015;6:7035 pubmed publisher
  164. Lin X, Xu W, Shao M, Fan Q, Wen G, Li C, et al. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration. BMC Complement Altern Med. 2015;15:126 pubmed publisher
  165. Modepalli V, Hinds L, Sharp J, Lefevre C, Nicholas K. Role of marsupial tammar wallaby milk in lung maturation of pouch young. BMC Dev Biol. 2015;15:16 pubmed publisher
  166. ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
  167. Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
  168. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, et al. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Cancer Lett. 2015;360:269-79 pubmed publisher
  169. Song E, Yu W, Xiong X, Kuang X, Ai Y, Xiong X. Astrocyte elevated gene-1 promotes progression of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition via Wnt signaling. Int J Gynecol Cancer. 2015;25:345-55 pubmed publisher
  170. Kitamura J, Uemura M, Kurozumi M, Sonobe M, Manabe T, Hiai H, et al. Chronic lung injury by constitutive expression of activation-induced cytidine deaminase leads to focal mucous cell metaplasia and cancer. PLoS ONE. 2015;10:e0117986 pubmed publisher
  171. Liu S, Lee W, Lai D, Wu S, Liu C, Tien H, et al. Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition. Mol Oncol. 2015;9:834-49 pubmed publisher
  172. Hsiao S, Chen M, Chen C, Chien M, Hua K, Hsiao M, et al. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Ann Surg Oncol. 2015;22 Suppl 3:S1556-65 pubmed publisher
  173. Traenkle B, Emele F, Anton R, Poetz O, Haeussler R, Maier J, et al. Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells. Mol Cell Proteomics. 2015;14:707-23 pubmed publisher
  174. Gong X, Yi J, Carmon K, Crumbley C, Xiong W, Thomas A, et al. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene. 2015;34:4692-701 pubmed publisher
  175. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman M, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21:899-906 pubmed publisher
  176. Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
  177. Jannasch K, Wegwitz F, Lenfert E, Maenz C, Deppert W, Alves F. Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination. Int J Cancer. 2015;137:25-36 pubmed publisher
  178. Figueira A, Gomes C, de Oliveira J, Vilhena H, Carvalheira J, de Matos A, et al. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas. BMC Vet Res. 2014;10:270 pubmed publisher
  179. Easter S, Mitchell E, Baxley S, Desmond R, Frost A, Serra R. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors. PLoS ONE. 2014;9:e113247 pubmed publisher
  180. Akgul Y, Word R, Ensign L, Yamaguchi Y, Lydon J, Hanes J, et al. Hyaluronan in cervical epithelia protects against infection-mediated preterm birth. J Clin Invest. 2014;124:5481-9 pubmed publisher
  181. Ciamporcero E, Miles K, Adelaiye R, Ramakrishnan S, Shen L, Ku S, et al. Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. Mol Cancer Ther. 2015;14:101-10 pubmed publisher
  182. Griner N, Young D, Chaudhary P, Mohamed A, Huang W, Chen Y, et al. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. Mol Cancer Res. 2015;13:368-79 pubmed publisher
  183. Soncini D, Caffa I, Zoppoli G, Cea M, Cagnetta A, Passalacqua M, et al. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. J Biol Chem. 2014;289:34189-204 pubmed publisher
  184. Sako Kubota K, Tanaka N, Nagae S, Meng W, Takeichi M. Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions. Mol Biol Cell. 2014;25:3851-60 pubmed publisher
  185. Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem. 2014;289:31526-33 pubmed publisher
  186. Tang J, Shen L, Yang Q, Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif. 2014;47:427-34 pubmed publisher
  187. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed publisher
  188. Nagakura I, Van Wart A, Petravicz J, Tropea D, Sur M. STAT1 regulates the homeostatic component of visual cortical plasticity via an AMPA receptor-mediated mechanism. J Neurosci. 2014;34:10256-63 pubmed publisher
  189. Liu J, Ke F, Xu Z, Liu Z, Zhang L, Yan S, et al. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS ONE. 2014;9:e101137 pubmed publisher
  190. Liang W, Hao Z, Han J, Zhu D, Jin Z, Xie W. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Urol Oncol. 2014;32:855-63 pubmed publisher
  191. Kowtharapu B, Stahnke T, Wree A, Guthoff R, Stachs O. Corneal epithelial and neuronal interactions: role in wound healing. Exp Eye Res. 2014;125:53-61 pubmed publisher
  192. Lee M, Kim S, Kim B, Won C, Nam S, Kang S, et al. Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation. Biochim Biophys Acta. 2014;1843:2037-54 pubmed publisher
  193. Raimondi L, Amodio N, Di Martino M, Altomare E, Leotta M, Caracciolo D, et al. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity. Oncotarget. 2014;5:3039-54 pubmed
  194. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  195. Bao Y, Cao X, Luo D, Sun R, Peng L, Wang L, et al. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle. 2014;13:1958-69 pubmed publisher
  196. Serna A, Galán Cobo A, Rodrigues C, Sánchez Gomar I, Toledo Aral J, Moura T, et al. Functional inhibition of aquaporin-3 with a gold-based compound induces blockage of cell proliferation. J Cell Physiol. 2014;229:1787-801 pubmed publisher
  197. Clarke J, Hardwick R, Lake A, Lickteig A, Goedken M, Klaassen C, et al. Synergistic interaction between genetics and disease on pravastatin disposition. J Hepatol. 2014;61:139-47 pubmed publisher
  198. Chen D, Sun Y, Yuan Y, Han Z, Zhang P, Zhang J, et al. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLoS Genet. 2014;10:e1004177 pubmed publisher
  199. Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer. 2014;110:1497-505 pubmed publisher
  200. Berkenkamp B, Susnik N, Baisantry A, Kuznetsova I, Jacobi C, Sörensen Zender I, et al. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE. 2014;9:e88071 pubmed publisher
  201. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher
  202. Park J, Morley T, Scherer P. Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med. 2013;5:935-48 pubmed publisher
  203. Maier B, Kirsch M, Anderhub S, Zentgraf H, Krämer A. The novel actin/focal adhesion-associated protein MISP is involved in mitotic spindle positioning in human cells. Cell Cycle. 2013;12:1457-71 pubmed publisher
  204. Reginensi A, Scott R, Gregorieff A, Bagherie Lachidan M, Chung C, Lim D, et al. Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 2013;9:e1003380 pubmed publisher